LU Dan
Southwest Medical University, Luzhou, Sichuan 646000, ChinaLIU Kai-Xiang
Department of Nephrology, the Second Clinical College of North Sichuan Medical College,XIA Meng-Di
Department of Nephrology, the Second Clinical College of North Sichuan Medical College,ZHAO Yu-Zhang
Merck Pharmaceutical Co.Ltd.-The Hypertension, Dyslipidemia and Type 2 Diabetes Community Project Management Working Group of Nanchong Central Hospital, Nanchong, Sichuan 637000, ChinaFENG Sheng-Gang
Department of Nephrology, the Second Clinical College of North Sichuan Medical College,XIE Xi-Sheng
Department of Nephrology, the Second Clinical College of North Sichuan Medical College, ;Merck Pharmaceutical Co.Ltd.-The Hypertension, Dyslipidemia and Type 2 Diabetes Community Project Management Working Group of Nanchong Central Hospital, Nanchong, Sichuan 637000, China1.Southwest Medical University, Luzhou, Sichuan 646000, China;2.Department of Nephrology, the Second Clinical College of North Sichuan Medical College, ;3.Merck Pharmaceutical Co. Ltd.-The Hypertension, Dyslipidemia and Type 2 Diabetes Community Project Management Working Group of Nanchong Central Hospital, Nanchong, Sichuan 637000, China)
R18
LU Dan, LIU Kai-Xiang, XIA Meng-Di, ZHAO Yu-Zhang, FENG Sheng-Gang, XIE Xi-Sheng. Epidemiological investigation and risk factors analysis of hypertension in middle-aged and elderly residents in the community[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2018,26(3):300-305.
Copy